Literature DB >> 16222334

A genome-wide scan for attention-deficit/hyperactivity disorder in 155 German sib-pairs.

J Hebebrand1, A Dempfle, K Saar, H Thiele, B Herpertz-Dahlmann, M Linder, H Kiefl, H Remschmidt, U Hemminger, A Warnke, U Knölker, P Heiser, S Friedel, A Hinney, H Schäfer, P Nürnberg, K Konrad.   

Abstract

Three groups have previously performed genome scans in attention-deficit/hyperactivity disorder (ADHD); linkage to chromosome 5p13 was detected in all of the respective studies. In the current study, we performed a whole-genome scan with 102 German families with two or more offspring who currently fulfilled the diagnostic criteria for ADHD. Including subsequent fine mapping on chromosome 5p, a total of 523 markers were genotyped. The highest nonparametric multipoint LOD score of 2.59 (empirical genome-wide significance 0.1) was obtained for chromosome 5p at 17 cM (according to the Marshfield map). Subsequent analyses revealed (a) a higher LOD score of 3.37 at 39 cM for a quantitative severity score based on symptoms of inattention than for hyperactivity/impulsivity (LOD score of 1.11 at 59 cM), and (b) an HLOD of 4.75 (empirical genome-wide significance 0.001) based on a parametric model assuming dominant inheritance. The locus of the solute carrier 6A3 (SLC6A3; dopamine transporter 1; DAT1) localizes to 5p15.33; the gene has repeatedly been implicated in the etiology of ADHD. However, in our sample the DAT1 VNTR did not show association with ADHD. We additionally identified nominal evidence for linkage to chromosomes 6q, 7p, 9q, 11 q, 12q and 17p, which had also been identified in previous scans. Despite differences in ethnicity, ascertainment and phenotyping schemes, linkage results in ADHD appear remarkably consistent.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16222334     DOI: 10.1038/sj.mp.4001761

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  47 in total

1.  Identifying loci for the overlap between attention-deficit/hyperactivity disorder and autism spectrum disorder using a genome-wide QTL linkage approach.

Authors:  Judith S Nijmeijer; Alejandro Arias-Vásquez; Nanda N J Rommelse; Marieke E Altink; Richard J L Anney; Philip Asherson; Tobias Banaschewski; Cathelijne J M Buschgens; Ellen A Fliers; Michael Gill; Ruud B Minderaa; Luise Poustka; Joseph A Sergeant; Jan K Buitelaar; Barbara Franke; Richard P Ebstein; Ana Miranda; Fernando Mulas; Robert D Oades; Herbert Roeyers; Aribert Rothenberger; Edmund J S Sonuga-Barke; Hans-Christoph Steinhausen; Stephen V Faraone; Catharina A Hartman; Pieter J Hoekstra
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2010-05-20       Impact factor: 8.829

Review 2.  Genetics in child and adolescent psychiatry: methodological advances and conceptual issues.

Authors:  Sarah Hohmann; Nicoletta Adamo; Benjamin B Lahey; Stephen V Faraone; Tobias Banaschewski
Journal:  Eur Child Adolesc Psychiatry       Date:  2015-04-08       Impact factor: 4.785

3.  Association of the cannabinoid receptor gene (CNR1) with ADHD and post-traumatic stress disorder.

Authors:  Ake T Lu; Matthew N Ogdie; Marjo-Ritta Järvelin; Irma K Moilanen; Sandra K Loo; James T McCracken; James J McGough; May H Yang; Leena Peltonen; Stanley F Nelson; Rita M Cantor; Susan L Smalley
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2008-12-05       Impact factor: 3.568

4.  Pathogenesis and pathophysiology of attention-deficit/hyperactivity disorder: from childhood to adulthood.

Authors:  M Gerlach; J Deckert; A Rothenberger; A Warnke
Journal:  J Neural Transm (Vienna)       Date:  2008       Impact factor: 3.575

Review 5.  Attention deficit hyperactivity disorder.

Authors:  Marguerite Matthews; Joel T Nigg; Damien A Fair
Journal:  Curr Top Behav Neurosci       Date:  2014

Review 6.  ADHD and smoking: from genes to brain to behavior.

Authors:  Francis Joseph McClernon; Scott Haden Kollins
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

Review 7.  Genetic aspects in attention-deficit/hyperactivity disorder.

Authors:  O Albayrak; S Friedel; B G Schimmelmann; A Hinney; J Hebebrand
Journal:  J Neural Transm (Vienna)       Date:  2008-01-16       Impact factor: 3.575

8.  Adrenergic alpha2A receptor gene and response to methylphenidate in attention-deficit/hyperactivity disorder-predominantly inattentive type.

Authors:  T L da Silva; T G Pianca; T Roman; M H Hutz; S V Faraone; M Schmitz; L A Rohde
Journal:  J Neural Transm (Vienna)       Date:  2008-01-16       Impact factor: 3.575

9.  Meta-analysis of genome-wide linkage scans of attention deficit hyperactivity disorder.

Authors:  Kaixin Zhou; Astrid Dempfle; Mauricio Arcos-Burgos; Steven C Bakker; Tobias Banaschewski; Joseph Biederman; Jan Buitelaar; F Xavier Castellanos; Alysa Doyle; Richard P Ebstein; Jenny Ekholm; Paola Forabosco; Barbara Franke; Christine Freitag; Susann Friedel; Michael Gill; Johannes Hebebrand; Anke Hinney; Christian Jacob; Klaus Peter Lesch; Sandra K Loo; Francisco Lopera; James T McCracken; James J McGough; Jobst Meyer; Eric Mick; Ana Miranda; Maximilian Muenke; Fernando Mulas; Stanley F Nelson; T Trang Nguyen; Robert D Oades; Matthew N Ogdie; Juan David Palacio; David Pineda; Andreas Reif; Tobias J Renner; Herbert Roeyers; Marcel Romanos; Aribert Rothenberger; Helmut Schäfer; Joseph Sergeant; Richard J Sinke; Susan L Smalley; Edmund Sonuga-Barke; Hans-Christoph Steinhausen; Emma van der Meulen; Susanne Walitza; Andreas Warnke; Cathryn M Lewis; Stephen V Faraone; Philip Asherson
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2008-12-05       Impact factor: 3.568

10.  Genome-wide association scan of attention deficit hyperactivity disorder.

Authors:  Benjamin M Neale; Jessica Lasky-Su; Richard Anney; Barbara Franke; Kaixin Zhou; Julian B Maller; Alejandro Arias Vasquez; Philip Asherson; Wai Chen; Tobias Banaschewski; Jan Buitelaar; Richard Ebstein; Michael Gill; Ana Miranda; Robert D Oades; Herbert Roeyers; Aribert Rothenberger; Joseph Sergeant; Hans Christoph Steinhausen; Edmund Sonuga-Barke; Fernando Mulas; Eric Taylor; Nan Laird; Christoph Lange; Mark Daly; Stephen V Faraone
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2008-12-05       Impact factor: 3.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.